Efficacy and safety of nivolumab plus chemotherapy in patients with advanced gastric cancer with massive ascites
Nivolumab plus chemotherapy demonstrated modest efficacy and acceptable toxicity in patients with AGC and HAB.
Authors
- Chinatsu Makiyama
- Akio Nakasya (ORCID: https://orcid.org/0000-0001-5244-5392)
- Akitoshi SASAMOTO
- Reiji Higashi (ORCID: https://orcid.org/0000-0002-4307-4312)
- Hiroki Nagai
- Reo Omori
- Hisateru Yasui
- Hironaga Satake
- Toshihiko Matsumoto
- Soma Sugimoto
Institutions
- Kochi Medical School Hospital (JP)
- Ichinomiya Municipal City Hospital (JP)
- Ichinomiya Kenshin College (JP)
- Kobe City Medical Center General Hospital (JP)
Publication Details
- Journal
- World Journal of Gastrointestinal Oncology
- Published
- 2026-01-09
- DOI
- https://doi.org/10.4251/wjgo.v18.i1.112944
- Primary Topic
- Gastric Cancer Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00